Quipt Home Medical Corp. (QIPT)
USD 2.41
(-7.49%)
USD 2.41
(-7.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 98.94 Million USD | 272.51% |
| 2022 | 26.56 Million USD | -1.82% |
| 2021 | 27.05 Million USD | 18.32% |
| 2020 | 22.86 Million CAD | 18.35% |
| 2019 | 19.31 Million CAD | 18.31% |
| 2018 | 16.32 Million CAD | 26.54% |
| 2017 | 12.9 Million CAD | 17.22% |
| 2016 | 11 Million CAD | 66.62% |
| 2015 | 6.6 Million CAD | 413.67% |
| 2014 | 1.28 Million CAD | 122.69% |
| 2013 | 577.62 Thousand CAD | 14.52% |
| 2012 | 504.4 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | -100.0% |
| 2009 | 56.78 Thousand CAD | -90.69% |
| 2008 | 610.17 Thousand CAD | -49.25% |
| 2007 | 1.2 Million CAD | 75.37% |
| 2006 | 685.5 Thousand CAD | -1.14% |
| 2005 | 693.41 Thousand CAD | -51.33% |
| 2004 | 1.42 Million CAD | 79.84% |
| 2003 | 792.29 Thousand CAD | 13.95% |
| 2002 | 695.3 Thousand CAD | 54.78% |
| 2001 | 449.23 Thousand CAD | -7.73% |
| 2000 | 486.88 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 96.71 Million USD | -2.18% |
| 2024 Q2 | 97.86 Million USD | 0.73% |
| 2024 Q3 | 98.64 Million USD | 1.54% |
| 2023 Q2 | 107.31 Million USD | 302.38% |
| 2023 Q1 | 26.67 Million USD | 0.41% |
| 2023 Q3 | 96.88 Million USD | -9.71% |
| 2023 Q4 | 98.94 Million USD | 2.12% |
| 2023 FY | 98.94 Million USD | 272.51% |
| 2022 FY | 26.56 Million USD | -1.82% |
| 2022 Q1 | 26.88 Million USD | -0.61% |
| 2022 Q4 | 26.56 Million USD | -27.78% |
| 2022 Q2 | 24.52 Million USD | -8.78% |
| 2022 Q3 | 36.78 Million USD | 49.94% |
| 2021 Q1 | 24.78 Million USD | 8.39% |
| 2021 FY | 27.05 Million USD | 18.32% |
| 2021 Q4 | 27.05 Million USD | -1.83% |
| 2021 Q3 | 27.55 Million USD | -8.94% |
| 2021 Q2 | 30.26 Million USD | 22.11% |
| 2020 Q4 | 22.86 Million CAD | 0.93% |
| 2020 FY | 22.86 Million CAD | 18.35% |
| 2020 Q3 | 22.65 Million CAD | 11.76% |
| 2020 Q1 | 23.39 Million CAD | 21.12% |
| 2020 Q2 | 20.27 Million CAD | -13.37% |
| 2019 Q2 | 19.46 Million CAD | 37.23% |
| 2019 Q3 | 19.2 Million CAD | -1.33% |
| 2019 Q4 | 19.31 Million CAD | 0.57% |
| 2019 FY | 19.31 Million CAD | 18.31% |
| 2019 Q1 | 14.18 Million CAD | -13.12% |
| 2018 Q3 | 14.38 Million CAD | 3.55% |
| 2018 Q1 | 13.23 Million CAD | 2.57% |
| 2018 FY | 16.32 Million CAD | 26.54% |
| 2018 Q2 | 13.89 Million CAD | 4.96% |
| 2018 Q4 | 16.32 Million CAD | 13.51% |
| 2017 Q1 | 13.26 Million CAD | 20.49% |
| 2017 Q4 | 12.9 Million CAD | -23.17% |
| 2017 Q3 | 16.79 Million CAD | 12.89% |
| 2017 Q2 | 14.87 Million CAD | 12.16% |
| 2017 FY | 12.9 Million CAD | 17.22% |
| 2016 Q1 | 10.98 Million CAD | 66.32% |
| 2016 Q3 | 11.87 Million CAD | 1.47% |
| 2016 Q4 | 11 Million CAD | -7.29% |
| 2016 FY | 11 Million CAD | 66.62% |
| 2016 Q2 | 11.7 Million CAD | 6.49% |
| 2015 Q3 | 7.2 Million CAD | -1.72% |
| 2015 Q4 | 6.6 Million CAD | -8.32% |
| 2015 Q2 | 7.33 Million CAD | 35.59% |
| 2015 FY | 6.6 Million CAD | 413.67% |
| 2015 Q1 | 5.4 Million CAD | 320.46% |
| 2014 Q2 | 405.32 Thousand CAD | -10.38% |
| 2014 Q3 | 969.5 Thousand CAD | 139.19% |
| 2014 Q4 | 1.28 Million CAD | 32.68% |
| 2014 Q1 | 452.24 Thousand CAD | -21.71% |
| 2014 FY | 1.28 Million CAD | 122.69% |
| 2013 FY | 577.62 Thousand CAD | 14.52% |
| 2013 Q1 | 503.27 Thousand CAD | -0.22% |
| 2013 Q4 | 577.62 Thousand CAD | 19.3% |
| 2013 Q3 | 484.17 Thousand CAD | -2.46% |
| 2013 Q2 | 496.38 Thousand CAD | -1.37% |
| 2012 Q4 | 504.4 Thousand CAD | -30.17% |
| 2012 FY | 504.4 Thousand CAD | 0.0% |
| 2012 Q2 | 732.49 Thousand CAD | 64.62% |
| 2012 Q1 | 444.95 Thousand CAD | 0.0% |
| 2012 Q3 | 722.38 Thousand CAD | -1.38% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | 76.93 Thousand CAD | -32.05% |
| 2010 FY | - CAD | -100.0% |
| 2010 Q2 | 140.48 Thousand CAD | 82.61% |
| 2009 Q2 | 342.41 Thousand CAD | 32.31% |
| 2009 Q3 | 56.78 Thousand CAD | -83.42% |
| 2009 Q1 | 258.79 Thousand CAD | -64.54% |
| 2009 Q4 | 113.21 Thousand CAD | 99.39% |
| 2009 FY | 56.78 Thousand CAD | -90.69% |
| 2008 Q4 | 729.73 Thousand CAD | 19.6% |
| 2008 Q1 | 1.16 Million CAD | -4.38% |
| 2008 Q3 | 610.17 Thousand CAD | -43.28% |
| 2008 Q2 | 1.07 Million CAD | -7.39% |
| 2008 FY | 610.17 Thousand CAD | -49.25% |
| 2007 Q2 | 910.75 Thousand CAD | 44.3% |
| 2007 Q1 | 631.15 Thousand CAD | -2.27% |
| 2007 Q4 | 1.21 Million CAD | 1.06% |
| 2007 FY | 1.2 Million CAD | 75.37% |
| 2007 Q3 | 1.2 Million CAD | 32.0% |
| 2006 Q1 | 839.93 Thousand CAD | 20.47% |
| 2006 Q4 | 645.79 Thousand CAD | -5.79% |
| 2006 FY | 685.5 Thousand CAD | -1.14% |
| 2006 Q2 | 740.77 Thousand CAD | -11.81% |
| 2006 Q3 | 685.5 Thousand CAD | -7.46% |
| 2005 FY | 693.41 Thousand CAD | -51.33% |
| 2005 Q1 | 1.5 Million CAD | 1.93% |
| 2005 Q2 | 1.53 Million CAD | 2.27% |
| 2005 Q4 | 697.19 Thousand CAD | 0.55% |
| 2005 Q3 | 693.41 Thousand CAD | -54.96% |
| 2004 Q4 | 1.47 Million CAD | 3.66% |
| 2004 Q1 | 935.21 Thousand CAD | 5.53% |
| 2004 FY | 1.42 Million CAD | 79.84% |
| 2004 Q2 | 1.5 Million CAD | 60.75% |
| 2004 Q3 | 1.42 Million CAD | -5.22% |
| 2003 Q3 | 792.29 Thousand CAD | 5.88% |
| 2003 Q2 | 748.29 Thousand CAD | 2.97% |
| 2003 FY | 792.29 Thousand CAD | 13.95% |
| 2003 Q1 | 726.7 Thousand CAD | 6.77% |
| 2003 Q4 | 886.21 Thousand CAD | 11.85% |
| 2002 Q1 | 508.69 Thousand CAD | -5.75% |
| 2002 FY | 695.3 Thousand CAD | 54.78% |
| 2002 Q4 | 680.65 Thousand CAD | -2.11% |
| 2002 Q3 | 695.3 Thousand CAD | 53.55% |
| 2002 Q2 | 452.8 Thousand CAD | -10.99% |
| 2001 FY | 449.23 Thousand CAD | -7.73% |
| 2001 Q4 | 539.73 Thousand CAD | 0.0% |
| 2000 FY | 486.88 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 81.734% |
| Nemaura Medical Inc. | 20.03 Million USD | -393.973% |
| NeuroPace, Inc. | 72.39 Million USD | -36.672% |
| LENSAR, Inc. | 2.3 Million USD | -4185.123% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -1246.903% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -6103.354% |
| Apyx Medical Corporation | 38.5 Million USD | -156.989% |
| Cutera, Inc. | 431.91 Million USD | 77.092% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -532.914% |
| BioSig Technologies, Inc. | 452 Thousand USD | -21790.155% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -152.278% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 94.116% |
| Axonics, Inc. | 27.61 Million USD | -258.27% |
| IRIDEX Corporation | 2.74 Million USD | -3503.186% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -24.922% |
| TELA Bio, Inc. | 42.78 Million USD | -131.284% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -26713.956% |
| RxSight, Inc. | 3.01 Million USD | -3184.977% |
| Align Technology, Inc. | 96.96 Million USD | -2.037% |
| INVO Bioscience, Inc. | 8.68 Million USD | -1039.435% |
| electroCore, Inc. | 626 Thousand USD | -15705.671% |
| Telesis Bio, Inc. | 34.38 Million USD | -187.794% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -863.312% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -240.75% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -4113.948% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -548.597% |
| Dynatronics Corporation | 6.68 Million USD | -1379.429% |
| Modular Medical, Inc. | 1.19 Million USD | -8214.58% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -37664.694% |
| Talis Biomedical Corporation | 19.66 Million USD | -403.068% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -7148.396% |
| InMode Ltd. | 9.01 Million USD | -997.3% |
| Envoy Medical, Inc. | 404 Thousand USD | -24390.965% |
| Bruker Corporation | 1.37 Billion USD | 92.828% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -173485.086% |
| DexCom, Inc. | 2.59 Billion USD | 96.186% |
| Nexalin Technology, Inc. | 4463.00 USD | -2216872.866% |
| PAVmed Inc | 48.72 Million USD | -103.065% |
| Viveve Medical, Inc. | 5.34 Million USD | -1749.757% |
| Cerus Corporation | 95.99 Million USD | -3.067% |
| Movano Inc. | 252 Thousand USD | -39163.293% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -198.256% |
| Nexalin Technology, Inc. | 4463.00 USD | -2216872.866% |
| IceCure Medical Ltd | 599 Thousand USD | -16418.113% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 76.196% |
| enVVeno Medical Corporation | 1.4 Million USD | -6957.311% |
| 908 Devices Inc. | 5.94 Million USD | -1564.315% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -609.73% |
| Orthofix Medical Inc. | 134.19 Million USD | 26.271% |
| Surmodics, Inc. | 29.4 Million USD | -236.485% |
| Nuwellis, Inc. | 981 Thousand USD | -9985.984% |
| Outset Medical, Inc. | 136.18 Million USD | 27.348% |
| Venus Concept Inc. | 79.69 Million USD | -24.15% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 23.786% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -40.739% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -1078.46% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -10422.367% |
| Inogen, Inc. | 21.92 Million USD | -351.323% |
| IRadimed Corporation | 2.04 Million USD | -4742.947% |
| MaxCyte, Inc. | 18.74 Million USD | -427.896% |
| Pulmonx Corporation | 41.42 Million USD | -138.855% |
| PAVmed Inc. | 48.72 Million USD | -103.065% |
| iCAD, Inc. | 461 Thousand USD | -21362.798% |
| OrthoPediatrics Corp. | 23.76 Million USD | -316.429% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -4855.848% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -20010.835% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -53556.995% |
| SI-BONE, Inc. | 38.99 Million USD | -153.753% |
| Semler Scientific, Inc. | 70 Thousand USD | -141247.856% |
| Beyond Air, Inc. | 17.83 Million USD | -454.709% |
| FONAR Corporation | 41.67 Million USD | -137.412% |
| AxoGen, Inc. | 69.29 Million USD | -42.792% |
| Biotricity, Inc. | 23.87 Million USD | -314.357% |
| Cytosorbents Corporation | 18.31 Million USD | -440.287% |
| ZimVie Inc. | 521.92 Million USD | 81.043% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -96.414% |
| Inari Medical, Inc. | 32.04 Million USD | -208.745% |
| UFP Technologies, Inc. | 46.03 Million USD | -114.922% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -4855.848% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -3121.801% |
| Sight Sciences, Inc. | 35.41 Million USD | -179.391% |
| Insulet Corporation | 1.44 Billion USD | 93.171% |
| Profound Medical Corp. | 7.9 Million USD | -1152.391% |
| Bioventus Inc. | 409.47 Million USD | 75.837% |
| InspireMD, Inc. | 1.59 Million USD | -6103.354% |
| BrainsWay Ltd. | 471 Thousand USD | -20907.112% |
| BIOLASE, Inc. | 17.91 Million USD | -452.448% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -9447.416% |
| Tenon Medical, Inc. | 1.17 Million USD | -8335.081% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -9774.601% |
| CVRx, Inc. | 30.61 Million USD | -223.207% |
| AdaptHealth Corp. | 2.29 Billion USD | 95.688% |
| Sintx Technologies, Inc. | 4.24 Million USD | -2230.824% |
| Acutus Medical, Inc. | 38.47 Million USD | -157.136% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -4859.574% |
| NanoVibronix, Inc. | 5000.00 USD | -1978769.98% |
| Quanterix Corporation | 41.46 Million USD | -138.625% |
| LivaNova PLC | 640.4 Million USD | 84.55% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -3208.52% |
| Varex Imaging Corporation | 469.5 Million USD | 78.926% |
| Vivani Medical, Inc. | 20.69 Million USD | -378.08% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -4113.948% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -12536.462% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 89.406% |
| TransMedics Group, Inc. | 515.94 Million USD | 80.823% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -5099.343% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -40976.529% |
| Spectral AI, Inc. | 1.28 Million USD | -7575.989% |
| Hyperfine, Inc. | 185 Thousand USD | -53382.972% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 48.527% |
| Biomerica, Inc. | 785 Thousand USD | -12504.267% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -21912.734% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -26633.9% |
| Silk Road Medical, Inc | 84.63 Million USD | -16.909% |